DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
61.63
+3.81 (6.59%)
At close: May 15, 2026, 4:00 PM EDT
61.50
-0.13 (-0.21%)
After-hours: May 15, 2026, 7:39 PM EDT
DexCom Stock Forecast
Stock Price Forecast
The 21 analysts that cover DexCom stock have a consensus rating of "Strong Buy" and an average price target of $84.67, which forecasts a 37.38% increase in the stock price over the next year. The lowest target is $67 and the highest is $102.
Price Target: $84.67 (+37.38%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 10 | 10 | 10 |
| Buy | 7 | 8 | 8 | 8 | 8 | 8 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 22 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $84 → $79 | Strong Buy | Maintains | $84 → $79 | +28.18% | May 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $95 → $100 | Strong Buy | Maintains | $95 → $100 | +62.26% | May 1, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $84 → $75 | Strong Buy | Maintains | $84 → $75 | +21.69% | May 1, 2026 |
| Barclays | Barclays | Sell Maintains $72 → $67 | Sell | Maintains | $72 → $67 | +8.71% | May 1, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $77 → $84 | Strong Buy | Maintains | $77 → $84 | +36.30% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
5.33B
from 4.66B
Increased by 14.35%
Revenue Next Year
5.97B
from 5.33B
Increased by 11.97%
EPS This Year
2.61
from 2.09
Increased by 24.75%
EPS Next Year
3.09
from 2.61
Increased by 18.72%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.5B | 6.3B | ||||||
| Avg | 5.3B | 6.0B | ||||||
| Low | 5.1B | 5.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 18.8% | 18.5% | ||||||
| Avg | 14.4% | 12.0% | ||||||
| Low | 8.7% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.78 | 3.43 | |||
| Avg | 2.61 | 3.09 | |||
| Low | 2.39 | 2.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 33.2% | 31.7% | |||
| Avg | 24.8% | 18.7% | |||
| Low | 14.4% | 4.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.